Italy Records First Human Case of H9N2 Bird Flu Virus in Europe
First Human Case Recorded in Italy
The health authorities in Italy announced the first human infection with the H9N2 bird flu virus in Europe, after diagnosing a case in a child on March 25, 2026.
The child was infected outside the European continent before returning to Northern Italy.
Although the symptoms were not severe, he was isolated in the hospital as a precautionary measure.
H9N2 Virus and Its Belonging to the Influenza A Family
The H9N2 virus belongs to the family of influenza A viruses, which is the same family that includes seasonal viruses affecting humans.
The H9N2 virus is classified as a low pathogenic virus, as it often causes mild symptoms, especially in humans.
Transmission of H9N2 Virus to Humans is Rare
Studies indicate that the transmission of the H9N2 virus from birds to humans is rare and usually occurs through direct contact with poultry or contaminated environments.
Hundreds of cases have been recorded previously in Asia and Africa, without the virus becoming a widespread threat.
Assessment of Current Risk Level
So far, the risk of H9N2 spreading among humans is considered very low, as the virus is still not well adapted to the human body and requires genetic mutations to spread easily.
Health authorities are monitoring contacts to ensure no further transmission occurs, which is a standard precautionary measure.
Importance of Monitoring Bird Flu Viruses
Despite the limited risk, experts emphasize the importance of continuous monitoring of bird flu viruses.
Some other strains, such as H5N1, are more dangerous and have shown a greater ability to infect mammals, highlighting the need for scientific vigilance to avoid any unexpected developments.
Summary of the News
The case recorded in Italy does not pose an immediate threat to humans, but it serves as a reminder that bird viruses can change and mutate.
The risk remains low currently, but expert monitoring of emerging animal viruses is essential for public health.
